Victory Capital Management
ONCS

Victory Capital Management’s OncoSec Medical Incorporated ONCS Stock Holding History

Victory Capital Management’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-327
Closed -$10K – 3750
2020
Q1 		$10K Buy
+327
New +$12.2K ﹤0.01% 3340
2019
Q4 		– Sell
-69
Closed -$3K – 3773
2019
Q3 		$3K Buy
+69
New +$3.24K ﹤0.01% 3605

Other funds holding ONCS

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Victory Capital Management's ONCS Position: Q2 2020 in Review

Victory Capital Management sold out of OncoSec Medical Incorporated (ONCS) in Q2 2020, closing a stake of 327 shares — an estimated $10K sold.

Victory Capital Management first reported a position in ONCS in Q3 2019 and held it in 2 quarters. The position peaked at $10K in Q1 2020. 16 funds tracked by Wall St. Rank hold ONCS as of Q2 2020.

  • Victory Capital Management reported no remaining OncoSec Medical Incorporated position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 327 OncoSec Medical Incorporated shares in Q2 2020, an estimated $10K.
  • Victory Capital Management first reported a position in OncoSec Medical Incorporated in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's OncoSec Medical Incorporated position peaked at $10K in Q1 2020.
  • 16 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.